- Home
- VCRE vs MFM Comparison
VCRE vs MFM Comparison
Compare VCRE & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | VCRE | MFM |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Finance Companies |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 224.5M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | VCRE | MFM |
|---|---|---|
| Price | $9.44 | $5.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $29.97 | N/A |
| AVG Volume (30 Days) | 20.2K | ★ 479.1K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | N/A |
| Revenue This Year | $101.29 | N/A |
| Revenue Next Year | $481.15 | N/A |
| P/E Ratio | ★ N/A | $172.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.88 | $4.75 |
| 52 Week High | $14.01 | $5.67 |
Technical Indicators
Market Signals| Indicator | VCRE | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 55.66 |
| Support Level | $8.70 | $4.75 |
| Resistance Level | $9.64 | $5.51 |
| Average True Range (ATR) | 0.51 | 0.09 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 19.38 | 65.42 |
Price Performance
Historical ComparisonAbout VCRE Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.